VGXI has set up an RNA pilot production suite at its facility in Woodlands, Texas citing growing demand from gene therapy developers.
The GMP-grade mRNA manufacturing unit will support customer projects from initial plasmid construction through linearization, in vitro translation, mRNA purification, and comprehensive quality control testing according to VGXI.
VGXI plans to launch clinical grade mRNA manufacturing services next year.
Methodical expansion
The pilot plant was set up as part of the VGXI licensing deal with the Houston Methodist Research Institute.
The CDMO said it will continue to work with the Institute’s RNACore group – a research team focused on RNA synthesis – to set up a large-scale GMP mRNA production facility.
